Loading IOL Chemicals and Pharmaceuticals…
| ₹ Cr | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 756 | 619 | 580 | 568 | 552 |
| Operating profit | 82 | 72 | 37 | 37 | 42 |
| Operating margin | 10.9% | 11.7% | 6.4% | 6.5% | 7.7% |
| Net profit | 64 | 53 | 21 | 30 | 34 |
| Net margin | 8.5% | 8.6% | 3.5% | 5.3% | 6.2% |
| EPS (₹) | 2.19 | 1.81 | 0.70 | 1.02 | 1.16 |
Quarters are labelled by period end.
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 2,308 | 2,068 | 2,119 | 2,202 |
| Operating profit | 190 | 131 | 168 | 180 |
| Operating margin | 8.2% | 6.3% | 7.9% | 8.2% |
| Net profit | 138 | 101 | 134 | 139 |
| Net margin | 6.0% | 4.9% | 6.3% | 6.3% |
| EPS (₹) | 4.69 | 3.44 | 4.58 | 4.74 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Total assets | 2,587 | 2,382 | 2,244 | 2,022 |
| Total liabilities | 788 | 694 | 633 | 514 |
| Shareholders’ equity | 1,799 | 1,688 | 1,612 | 1,508 |
| Total debt | 135 | 117 | 33 | 80 |
| Cash & equivalents | 65 | 78 | 8 | 1 |
| Debt / equity | 0.08 | 0.07 | 0.02 | 0.05 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Operating cash flow | 214 | 179 | 290 | 122 |
| Capital expenditure | -173 | -214 | -274 | -212 |
| Free cash flow | 41 | -35 | 16 | -90 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Return on equity | 7.7% | 6.0% | 8.3% | 9.2% |
| Return on assets | 5.3% | 4.2% | 6.0% | 6.9% |
| Net margin | 6.0% | 4.9% | 6.3% | 6.3% |
Source: Yahoo Finance. Figures in ₹ crore unless stated.
No analyst data available for IOLCP. Finnhub coverage is limited for some India-listed stocks.